Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Satoshi Inoue

1PUBLICATIONS

22CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 24, 2022

ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs.

Shuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata

Pageof 1

Frequent Collaborators

1 joint publications

Shuntaro Tsukamoto

1 joint publications

Naoko Hata Sugi

1 joint publications

Kyoko Nishibata

1 joint publications

Youya Nakazawa

1 joint publications

Daisuke Ito

1 joint publications

Sayo Fukushima

1 joint publications

Takayuki Nakagawa

1 joint publications

Kenji Ichikawa

1 joint publications

Yu Kato

1 joint publications

Dai Kakiuchi

Frequent Collaborators

1 joint publications

Shuntaro Tsukamoto

1 joint publications

Naoko Hata Sugi

1 joint publications

Kyoko Nishibata

1 joint publications

Youya Nakazawa

Top Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on : Jan 11, 2019

See more related videos

Top Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on : Jan 11, 2019

See more related videos